tradingkey.logo

IDEXX Laboratories Inc

IDXX

537.114USD

+2.804+0.52%
交易中 美東報價延遲15分鐘
43.37B總市值
48.46本益比TTM

IDEXX Laboratories Inc

537.114

+2.804+0.52%
關於 IDEXX Laboratories Inc 公司
IDEXX Laboratories, Inc. 開發、生產和分銷產品,並主要爲伴侶動物獸醫、牲畜和家禽、乳製品和水檢測行業提供服務。該公司還提供人類醫療即時診斷和實驗室診斷。其部門包括伴侶動物組 (CAG)、水質產品 (水) 以及牲畜、家禽和乳製品 (LPD)。CAG 部門爲伴侶動物獸醫行業提供基於診斷和信息管理的產品和服務,包括臨牀診斷解決方案、外部參考實驗室服務以及獸醫軟件和服務。其水部門提供測試解決方案,用於準確檢測和量化水中的各種微生物參數。其 LPD 部門提供診斷測試、服務和相關儀器,用於管理牲畜和家禽的健康狀況,以提高牛奶的質量和安全性。
公司簡介
公司代碼IDXX
公司名稱IDEXX Laboratories Inc
上市日期Jun 21, 1991
成立日期1983
CEOMr. Andrew Emerson
員工數量11000
證券類型Ordinary Share
年結日Jun 21
公司地址One Idexx Drive
城市WESTBROOK
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編04092-2041
電話12075560300
網址https://www.idexx.com/
公司代碼IDXX
上市日期Jun 21, 1991
成立日期1983
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
地區USD
名稱
營收
佔比
United States
654.86M
65.59%
Europe & Middle East & Africa (EMEA) (Region)
204.55M
20.49%
Asia Pacific
81.73M
8.19%
Canada
37.30M
3.74%
Latin America
19.99M
2.00%
業務
地區
業務USD
名稱
營收
佔比
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
股東統計
更新時間: 7月24日 週四
更新時間: 7月24日 週四
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
股東類型
持股股東
佔比
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
29.33%
Research Firm
3.99%
Pension Fund
2.25%
Bank and Trust
2.04%
Hedge Fund
1.86%
Sovereign Wealth Fund
1.32%
Individual Investor
0.68%
Family Office
0.48%
Other
1.57%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
2259
79.04M
98.28%
-694.13K
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
9.82M
12.21%
+146.37K
+1.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
6.76%
+113.70K
+2.14%
Mar 31, 2025
State Street Global Advisors (US)
3.65M
4.54%
+12.32K
+0.34%
Mar 31, 2025
Fundsmith LLP
2.65M
3.29%
-14.52K
-0.55%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.41M
3%
+112.62K
+4.90%
Mar 31, 2025
Baron Capital Management, Inc.
2.06M
2.56%
+54.26K
+2.71%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.87M
2.33%
+824.75K
+78.91%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
1.66M
2.07%
-25.31K
-1.50%
Jun 30, 2025
BlackRock Asset Management Ireland Limited
1.14M
1.42%
+15.87K
+1.41%
Mar 31, 2025
Principal Global Investors (Equity)
1.13M
1.4%
+414.80K
+58.32%
Mar 31, 2025
查看更多
持股ETF
更新時間: 7月6日 週日
更新時間: 7月6日 週日
機構名稱
佔比
ProShares Pet Care ETF
9.86%
First Trust Water ETF
4.85%
iShares U.S. Medical Devices ETF
4.46%
First Trust S&P 500 Economic Moat Index ETF
2.42%
Adaptive Core ETF
2.35%
Invesco S&P 500 Equal Weight Health Care ETF
2.14%
Putnam Sustainable Future ETF
1.99%
American Century Mid Cap Growth Impact ETF
1.93%
SPDR S&P Health Care Equipment ETF
1.85%
Tema Durable Quality ETF
1.83%
查看更多
ProShares Pet Care ETF
佔比9.86%
First Trust Water ETF
佔比4.85%
iShares U.S. Medical Devices ETF
佔比4.46%
First Trust S&P 500 Economic Moat Index ETF
佔比2.42%
Adaptive Core ETF
佔比2.35%
Invesco S&P 500 Equal Weight Health Care ETF
佔比2.14%
Putnam Sustainable Future ETF
佔比1.99%
American Century Mid Cap Growth Impact ETF
佔比1.93%
SPDR S&P Health Care Equipment ETF
佔比1.85%
Tema Durable Quality ETF
佔比1.83%
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有
KeyAI